China Regenerative Medicine International Limited (HKG:8158)
0.3600
-0.0150 (-4.00%)
Feb 13, 2026, 4:08 PM HKT
China Regenerative Medicine International Company Description
China Regenerative Medicine International Limited, an investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China.
The company operates through Aesthetic Medical and Beauty Services; and Medical Services segments. It offers medical beauty products and services; and medical products and services.
The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015.
China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
China Regenerative Medicine International Limited
| Country | Cayman Islands |
| Founded | 1995 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 24 |
| CEO | Chuang Wang |
Contact Details
Address: Miramar Tower Tsim Sha Tsui Hong Kong | |
| Phone | 852 3918 9000 |
| Website | crmi.hk |
Stock Details
| Ticker Symbol | 8158 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | HKD |
| ISIN Number | KYG2129W1125 |
| SIC Code | 8742 |
Key Executives
| Name | Position |
|---|---|
| Chuang Wang | Chief Executive Officer, Executive Chairman and Compliance Officer |
| Shibin Yan | Chief Financial Officer |
| Dr. Jinnan Zhang | Chief Technology Officer |
| Lok Tung Chan | Company Secretary |